Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00885248 | Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer | unknown | — | 70 | Asan Medical CenterOTHER | 1 | Apr 21, 2009 | clinicaltrials |
| NCT00259532 | Three New Methods for Diagnosing Pancreas Cancer | unknown | N/A | 80 | University of CopenhagenOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00024375 |
| DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer |
| unknown |
| Phase 2 |
| — |
| TheradexINDUSTRY |
| 4 |
| Feb 18, 2009 |
| clinicaltrials |
| NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00010088 | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00813696 | Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer(GIP-1) | unknown | Phase 3 | 400 | Istituti Tumori Giovanni Paolo IINETWORK | 1 | Dec 23, 2008 | clinicaltrials |
| NCT00809081 | Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy | unknown | Phase 3 | 38 | Yonsei UniversityOTHER | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00758381 | Metastatic Advanced Pancreas Sorafenib(MAPS) | unknown | Phase 2 | 114 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Oct 10, 2008 | clinicaltrials |
| NCT00024362 | BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075452 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma | unknown | Phase 3 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00268411 | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | unknown | Phase 3 | 80 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | May 27, 2008 | clinicaltrials |
| NCT00486460 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | unknown | Phase 3 | — | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 14, 2007 | clinicaltrials |
| NCT00149578 | A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 45 | National Health Research Institutes, TaiwanOTHER | 1 | May 17, 2007 | clinicaltrials |
| NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | unknown | Phase 2 | 80 | Seattle Cancer Treatment and Wellness CenterOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00160836 | Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter | unknown | Phase 1 | 68 | University Hospital, GenevaOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00419614 | Outcome of Pancreatic Stump Closure Following Resection of Tumors of the Head of the Pancreas. | unknown | — | — | Hillel Yaffe Medical CenterOTHER_GOV | 0 | Jan 8, 2007 | clinicaltrials |
| NCT00419627 | Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas | unknown | — | 160 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Jan 8, 2007 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00346281 | 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | unknown | Phase 2 | 15 | pSiMedica LimitedINDUSTRY | 2 | Jun 29, 2006 | clinicaltrials |
| NCT00197431 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | unknown | Phase 2 | — | Hamamatsu UniversityOTHER | 1 | Mar 22, 2006 | clinicaltrials |
| NCT00088660 | PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen | unknown | Phase 3 | 250 | Therion Biologics CorporationINDUSTRY | 1 | Feb 8, 2006 | clinicaltrials |
| NCT00057395 | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 40 | Aronex PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00081549 | Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies | unknown | Phase 1 / Phase 2 | 111 | Aronex PharmaceuticalsINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 21, 2009source: clinicaltrials